Home » Products » Anti Cancer Formulation » Erlotinib Tablet

Erlotinib Tablet



<< Previous    Erlotinib Tablet    Next >>
Product Description

To meet the distinct needs of our valued patrons, we are manufacturing, supplying and exporting Erlotinib Tablet. This tablet is used for treating non-small cell lung cancer. Offered tablet is used along with gemcitabine for the efficient treatment of pancreatic cancer that might has spread to other tissue or to the other parts of body. Available at 150mg, Erlotinib Tablet is one of the best solution to treat the cancer. Moreover, we stringently test this tablet for quality, ensuring best and highly reliable outcome for valued customers.

Features:

  • Reliable
  • Effective
  • Precise pH value
  • Accurate composition

Product Code : spr11      Brand Name :SPR ONCOCARE (P) LTD


SPR ONCOCARE (P) LTD
Other Products in 'Anti Cancer Formulation' category
Vandetanib- 300mg
Vandetanib- 300mg
Jakavi 5mg/15mg/20mg
Jakavi 5mg/15mg/20mg
Temonat
Temonat
Resof-L
Resof-L
Bandrone Ibandronic Acid
Bandrone Ibandronic Acid
Votrient
Votrient
 
View all products(49)
 
<< Back
X



Daclatasavir
Daclatasavir
Lenvatinib-10mg
Lenvatinib-10mg
Sofovir
Sofovir
Bandrone Lymfuda
Bandrone Lymfuda
Cervarix
Cervarix
Rivaroxaban
Rivaroxaban
Lenalid Lenalidomide
Lenalid Lenalidomide
Cipla Everolimus 10 MG
Cipla Everolimus 10 MG
Hepcinat
Hepcinat
Axitinib Pfizer 5 MG
Axitinib Pfizer 5 MG
Cipla Abiraterone
Cipla Abiraterone
Palbociclib- 125mg
Palbociclib- 125mg
Erlotinib Tablet
Erlotinib Tablet
Baceft
Baceft
Bupaven
Bupaven
Anthelz-3000
Anthelz-3000
Baceft-TZ
Baceft-TZ
FENVEN TM -3000
FENVEN TM -3000
Hepawell
Hepawell
Floragest Powder
Floragest Powder
Aisure
Aisure
Arthisol
Arthisol
Floragest Bolus
Floragest Bolus
 
Contact Details
No. 12, 100 Feet, Ring Road, BSK 3rd Stage, Bengaluru - 560085, Karnataka, India
CONTACT - Mr Shiva Prasad (CEO)

Send Inquiry Send SMS
IN China

Mail: yiruisha@hotmail.com
Mobile: 0086 10 57270002
 
SPR ONCOCARE All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.